All articles tagged with #ptsd
London’s Hackney Mosaic Project uses collaborative mosaic-making as a therapeutic activity for people with PTSD and other mental-health challenges, turning broken shards into public murals across Hackney (e.g., Shepherdess Walk, River Place Health Centre benches, Hackney Downs) and running weekly workshops, illustrating healing and community cohesion through art.
Scientists are making strides in memory editing, from animal studies that erase fear memories by targeting brain cells to noninvasive human approaches (CBT, EMDR, and a Tetris-based trick) that lessen flashbacks. Although these methods show promise, permanent memory erasure remains unproven and ethically fraught, with experts arguing for modulation over deletion to avoid impacts on identity, justice, and personal growth.
Jon Bernthal's Punisher returns in Punisher: One Last Kill, a brutal 48-minute Marvel Special Presentation that doubles as a PTSD-driven character study. The action is relentless and the gravesite scene is haunting, delivering a darker, more mature tone than typical MCU fare, while raising questions about how the anti-hero will fit into a PG-13 Spider-Man universe.
In mice, locally produced estrogen in the hippocampus shapes memory and fear after acute stress in both sexes; high estrogen levels impair trauma-related memory, while low estrogen during estrus can be protective, suggesting sex-specific chromatin remodeling that could influence PTSD risk and aging-related memory problems in humans.
World No. 1 Scottie Scheffler says it's hard to watch Gary Woodland battle PTSD after brain surgery in 2023, but admires his resilience and dedication, while Woodland praises Scheffler’s game and character — a mutual, supportive bond on and off the PGA Tour highlighted during the RBC Heritage.
Trump plans to sign an executive order to accelerate research into psychedelic drugs such as LSD, Ecstasy, and psilocybin and to ease federal restrictions, targeting PTSD, depression and other mental health conditions, with $50 million earmarked for state-level ibogaine studies — a push Texas has already backed with a $50 million commitment.
A Lancet Psychiatry analysis finds no reliable evidence that medicinal cannabis improves anxiety, depression, or PTSD, though it may help with epilepsy-related seizures, MS spasticity, and some pain. Evidence for other uses like autism or insomnia is weak, and there are risks such as cannabis-use disorder and, in cocaine-use disorder, increased cravings. With Australia’s prescriptions rising rapidly, researchers call for tighter regulation and more high-quality research before routine mental-health use.
A Dutch-led study links misophonia to shared genetic risk factors for psychiatric disorders such as anxiety, depression, and PTSD, using data from major genetic databases. Self-identified misophonia correlated with genes tied to psychiatric traits and tinnitus, with some overlap with PTSD genetics, hinting at shared biology and possible PTSD‑inspired therapies, though findings come from self-reported data in mostly European samples and need broader validation; ASD showed less association.
The White House is drafting an executive order to open the door to federal funding for research on ibogaine, a psychedelic used abroad to treat PTSD and brain injuries. It would not reclassify the drug (still Schedule I) but signals support for further U.S. studies on safety and effectiveness, with a focus on veterans. Evidence is limited—mostly small observational studies—with notable cardiac risks and several deaths reported; a Stanford study suggested potential PTSD relief when ibogaine is paired with magnesium, yet more rigorous trials are needed before any medical use.
A new study links the brain’s estrogen levels at the moment of trauma to PTSD risk: high hippocampal estrogen boosts neural plasticity, enabling more intense, lasting traumatic memories in both sexes, with memory disruption persisting longer in females due to receptor differences; the work suggests future treatments could target estrogen signaling to reduce long-term trauma effects.
Gary Woodland returns to Augusta for the Masters while openly battling severe anxiety and PTSD that make him fear for his safety; he relies on a security detail on the course and has described hypervigilance, including a Houston Open win where he fought through fear. After brain-lesion surgery in 2023, golf has given him purpose, but the internal battle persists as he focuses on taking it day by day and hopes his story inspires others facing mental-health challenges.
Gary Woodland says he’ll have enhanced security at the Masters after PTSD flared when fans got close during a Texas Open win, a condition tied to brain surgery in 2023. He credits TOUR security and his team for keeping him safe, using visible security cues to stay calm on each hole as he returns to Augusta National.
A wearable transcranial ultrasound device dampened amygdala activity during fear conditioning with snakes, slowing fear learning and, notably, accelerating the unlearning of fear after the trials ended—suggesting a noninvasive approach to enhance exposure therapy for anxiety and trauma-related disorders.
Gary Woodland won the Houston Open, his first PGA Tour title in seven years, finishing 21-under after a final-round 67 to beat Nicolai Hojgaard by five strokes. He cried after holing out, thanked his wife and team, and spoke about continuing his healing from brain surgery in 2023 and PTSD, saying he’s not giving up and focusing on the future, with Masters contention a possibility.
New research in mice shows two neuron types in the central amygdala—CRF+ cells driving high‑intensity escape and SOM+ cells promoting freezing—act as a neural switch that reshapes fear during extinction rather than erasing it, offering insight into the variability of PTSD symptoms and potential therapeutic targets.